Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia
Closed
Phase 3
This trial is for children and young people up to the age of 18 who have acute lymphoblastic leukaemia (ALL) that has come back after treatment. They must also be in a group called a ‘standard risk’ group.
Doctors use different risk groups according to:
how quickly the leukaemia came back
where the leukaemia came back (for example in the or )
whether you have B-cell ALL or a T-cell ALL
Knowing the risk group helps doctors to choose the best treatment. If you don’t know your risk group ask your doctor. They will be able to tell you.
We use the term 'you' in this summary, but if you are a parent, we are referring to your child.
Recruitment start: 19 October 2015
Recruitment end: 21 December 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Denise Bonney
Central Manchester University Hospitals NHS Foundation Trust
Charité - Universitätsmedizin Berlin
EU Seventh Framework Programme (FP7)
NIHR Clinical Research Network: Cancer
University of Manchester
Last reviewed: 15 Jul 2024
CRUK internal database number: 13515
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
